Exercise program aims to beat fatigue in testicular cancer survivors

NCT ID NCT05588700

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a one-year supervised physical activity program can reduce long-term fatigue in men treated for metastatic testicular cancer. 236 participants will be randomly assigned to either the exercise program or standard recommendations. The main goal is to measure fatigue levels three years after starting chemotherapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
supervised physical activity program
What this could lead to
If it works, this could provide a proven way to reduce chronic fatigue and improve quality of life for testicular cancer survivors.
What could go wrong
This is a behavioral intervention, not a drug, so effects may be modest. The trial is still recruiting and results won't be available for several years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC TESTICULAR CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AP-HP Tenon

    NOT_YET_RECRUITING

    Paris, 75020, France

  • CHU Jean Minjoz

    NOT_YET_RECRUITING

    Besançon, 25030, France

  • CHU Tours

    NOT_YET_RECRUITING

    Tours, 37000, France

  • Centre Antoine Lacassagne

    NOT_YET_RECRUITING

    Nice, 06189, France

  • Centre Eugène Marquis

    NOT_YET_RECRUITING

    Rennes, 35000, France

  • Centre François Baclesse

    NOT_YET_RECRUITING

    Caen, 14076, France

  • Centre Leon Berard

    RECRUITING

    Lyon, 69008, France

  • Centre Oscar Lambret

    NOT_YET_RECRUITING

    Lille, 59020, France

  • Institut Bergonié

    NOT_YET_RECRUITING

    Bordeaux, 33000, France

  • Institut Gustave Roussy

    RECRUITING

    Villejuif, 94800, France

  • Institut de Cancérologie de Lorraine

    NOT_YET_RECRUITING

    Angers, 49000, France

  • Institut de Cancérologie de Lorraine

    RECRUITING

    Nancy, 54519, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.